FDA Approved Products
1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
OTEZLA
apremilast
Peak
Amgen
ORAL · TABLET
2014
NDA0/100
OTIPRIO
ciprofloxacin
Peak
OTIC · INJECTABLE, SUSPENSION
2015
SMNDA0/100
OTREXUP
methotrexate
Peak
SUBCUTANEOUS · SOLUTION
2013
NDA0/100
OTREXUP PFS
methotrexate
Peak
SUBCUTANEOUS · SOLUTION
2013
NDA0/100
OXBRYTA
voxelotor
Peak
Pfizer
ORAL · TABLET, FOR SUSPENSION
2021
NDA0/100
OXBRYTA
voxelotor
Peak
Pfizer
ORAL · TABLET
2019
NDA0/100
OXLUMO
lumasiran
Peak
Alnylam Pharmaceuticals
SUBCUTANEOUS · SOLUTION
primary hyperoxaluria type 1 (PH1) to lower urinaryplasma oxalate levels in pediatric
2020
RNANDA0/100
OZEMPIC
semaglutide
Peak
Novo Nordisk
SUBCUTANEOUS · SOLUTION
2017
PeptideNDA0/100
OZOBAX
baclofen
Peak
ORAL · SOLUTION
2019
NDA0/100
OZOBAX DS
baclofen
Peak
ORAL · SOLUTION
2019
NDA0/100
PARSABIV
etelcalcetide
Peak
INTRAVENOUS · SOLUTION
2017
PeptideNDA0/100
PATADAY ONCE DAILY RELIEF
olopatadine hydrochloride
Peak
Alcon
OPHTHALMIC · SOLUTION/DROPS
2015
NDA0/100
PEDMARK
sodium thiosulfate
Peak
Fennec Pharmaceuticals
INTRAVENOUS · SOLUTION
ototoxicity associated with cisplatin in pediatric patients 1 month of ageolder with localized+1
2022
NDA0/100
PEMAZYRE
pemigatinib
Peak
Incyte
ORAL · TABLET
2020
SMNDA0/100
PEMFEXY
pemetrexed
Peak
Eagle Pharmaceuticals
INTRAVENOUS · SOLUTION
combination with cisplatin for the initial treatment of patients with malignant pleural mesothelioma whose disease is unresectablelung cancer
2020
NDA0/100
PERIKABIVEN IN PLASTIC CONTAINER
dextrose, soybean oil, electrolytes, lysine, phenylalanine, leucine, valine, threonine, methionine, isoleucine, tryptophan, alanine, arginine, glycine, proline, histidine, glutamic acid, serine, aspartic acid and tyrosine
Peak
Fresenius Kabi
INTRAVENOUS · EMULSION
2014
NDA0/100
PHENYLEPHRINE HYDROCHLORIDE
phenylephrine hydrochloride
Peak
OPHTHALMIC · SOLUTION/DROPS
2013
NDA0/100
PHENYLEPHRINE HYDROCHLORIDE
phenylephrine hydrochloride
Peak
Hikma
INTRAVENOUS · SOLUTION
2012
NDA0/100
PHEXXI
lactic acid, l-, citric acid monohydrate, and potassium bitartrate
Peak
Evofem Biosciences
VAGINAL · GEL
pregnancy in females of reproductive potential for use
2020
NDA0/100
PICATO
ingenol mebutate
Peak
Leo Pharma
TOPICAL · GEL
2012
NDA0/100
PIFELTRO
doravirine
Peak
Merck & Co.
ORAL · TABLET
2018
NDA0/100
PIQRAY
alpelisib
Peak
Novartis
ORAL · TABLET
combination with fulvestrant for the treatment of adults with hormone receptor (HR)-positivehuman epidermal growth factor receptor 2 (HER2)-negative+5
2019
SMNDA0/100
PIZENSY
lactitol
Peak
ORAL · SOLUTION
2020
NDA0/100
PLENVU
polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, ascorbic acid, sodium ascorbate
Peak
Salix Pharmaceuticals
ORAL · FOR SOLUTION
2018
NDA0/100